PRTA

Prothena Corporation plc Ordinary Shares#4 · 2021HTFC

Yearly return

+111%

Peak return

+241%

Max drawdown

-49%

ADR (20 days)

+7.2%

Base

24 days / -26.9%

Prior run

+245%

Breakout volume

1.3x

Pivot

$73.51

Catalyst Relative Staerke/Technik2021-09-09Here's Why Prothena (PRTA) is a Great Momentum Stock to BuyZacks Investment Research

Kein klarer externer Katalysator in der News-Abdeckung; technische relative Staerke dominiert.

Healthcare · Healthcare & Biotech

Continue in the full Atlas

Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare PRTA with the current market directly.